Translation of pharmacogenetics into clinically relevant testing modalities

L. M. Baudhuin, L. J. Langman, D. J. O'Kane

Research output: Contribution to journalShort survey

14 Citations (Scopus)

Abstract

Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

Original languageEnglish (US)
Pages (from-to)373-376
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume82
Issue number4
DOIs
StatePublished - Oct 2007

Fingerprint

Pharmacogenetics
Succinylcholine
Psychotropic Drugs
Isoniazid
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Anticoagulants
Drug Therapy
Research

ASJC Scopus subject areas

  • Pharmacology

Cite this

Translation of pharmacogenetics into clinically relevant testing modalities. / Baudhuin, L. M.; Langman, L. J.; O'Kane, D. J.

In: Clinical Pharmacology and Therapeutics, Vol. 82, No. 4, 10.2007, p. 373-376.

Research output: Contribution to journalShort survey

Baudhuin, L. M. ; Langman, L. J. ; O'Kane, D. J. / Translation of pharmacogenetics into clinically relevant testing modalities. In: Clinical Pharmacology and Therapeutics. 2007 ; Vol. 82, No. 4. pp. 373-376.
@article{cde988d0f6684992be1e285be4653a59,
title = "Translation of pharmacogenetics into clinically relevant testing modalities",
abstract = "Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.",
author = "Baudhuin, {L. M.} and Langman, {L. J.} and O'Kane, {D. J.}",
year = "2007",
month = "10",
doi = "10.1038/sj.clpt.6100350",
language = "English (US)",
volume = "82",
pages = "373--376",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Translation of pharmacogenetics into clinically relevant testing modalities

AU - Baudhuin, L. M.

AU - Langman, L. J.

AU - O'Kane, D. J.

PY - 2007/10

Y1 - 2007/10

N2 - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

AB - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

UR - http://www.scopus.com/inward/record.url?scp=34548668192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548668192&partnerID=8YFLogxK

U2 - 10.1038/sj.clpt.6100350

DO - 10.1038/sj.clpt.6100350

M3 - Short survey

C2 - 17851577

AN - SCOPUS:34548668192

VL - 82

SP - 373

EP - 376

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -